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ABSTRACT Melatonin is a small amino acid derivative hormone of the pineal gland. Melatonin quickly and reversibly
blocked Kv1.3 channels, the predominant voltage-gated potassium channel in human T-lymphocytes, acting from the
extracellular side. The block did not show state or voltage dependence and was associated with an increased inactivation rate
of the current. A half-blocking concentration of 1.5 mM was obtained from the reduction of the peak current. We explored
several models to describe the stoichiometry of melatonin-Kv1.3 interaction considering one or four independent binding sites
per channel. The model in which the occupancy of one of four binding sites by melatonin is sufficient to block the channels
gives the best fit to the dose-response relationship, although all four binding sites can be occupied by the drug. The
dissociation constant for the individual binding sites is 8.11 mM. Parallel application of charybdotoxin and melatonin showed
that both compounds can simultaneously bind to the channels, thereby localizing the melatonin binding site out of the pore
region. However, binding of tetraethylammonium to its receptor decreases the melatonin affinity, and vice versa. Thus, the
occupancy of the two separate receptor sites allosterically modulates each other.
INTRODUCTION
Specific peptide and nonpeptide channel blockers are
widely used to investigate the function of Kv1.3 and the
molecular mechanism of its operation (Aiyar et al., 1995).
Based on the mechanism of block there are two groups of
blockers in general: pore blockers and gating modifiers
(Hille, 1992). Pore blockers inhibit the K current by plug-
ging the pore of the channel. Peptide toxins such as charyb-
dotoxin (ChTx) and those of the scorpion Pandinus impera-
tor belong to this group; they bind to the channels with 1:1
stoichiometry (Goldstein and Miller, 1993; Pe´ter et al.,
1998). ChTx is a widely used pore blocker, which binds to
both voltage-gated and Ca2 activated K channels with
high affinity (Goldstein and Miller, 1993; MacKinnon and
Miller, 1988). Tetraethylammonium (TEA) is a quaternary
ammonium compound with a pore-blocking mechanism
similar to that of peptide toxins (Spruce et al., 1987; Yellen
et al., 1991).
Gating modifiers such as hanatoxin (HaTx) block the K
current by modifying the gating mechanism of the channel.
HaTx shifts the channel opening to more depolarized mem-
brane potentials. One HaTx molecule can bind to each of the
four subunits of the channel (Swartz and MacKinnon,
1997a, b).
Some channel blockers have only intracellular binding
sites, but they still have an effect when they are applied
from the extracellular side. Extracellularly applied 4-ami-
nopyridine passes through the membrane in its nonionized
form and acts in its ionized form from the intracellular side.
The binding site of 4-aminopyridine is on the S5 and S6
transmembrane segments (Rasmusson et al., 1995). The
mechanism of block by clofilium, a quaternary ammonium
compound with antiarrhythmic effect, was studied on hu-
man Kv1.5 delayed rectifier potassium channels (Malayev
et al., 1995). Clofilium penetrates the membrane; its binding
site is at the intracellular side of the channel close to the
pore, and it can be trapped in the channel when the channel
closes.
Voltage-gated potassium channels have two binding sites
for TEA: one on the intracellular and another one on the
extracellular side (MacKinnon and Yellen, 1990; Yellen et
al., 1991; Kirsch et al., 1991; Heginbotham and MacKin-
non, 1992). TEA binds to the channel with 1:1 stoichiom-
etry and plugs the pore of the channel from both sides. The
intracellular and extracellular binding sites for TEA are on
the linker between S5 and S6. The intracellular binding site
is in the electric field of the membrane 25% deep from the
cytosol causing a voltage-dependent block; however, the
extracellular site is more superficial, showing no or mild
voltage dependence of the block (Heginbotham and Mac-
Kinnon, 1992). At the extracellular TEA binding site the
rate of block and unblock is extremely fast, resulting in a
reduction of the single-channel current amplitudes (Kirsch
et al., 1991).
Recently, it has been shown that melatonin (N-acetyl-5-
methoxytryptamine, Fig. 1), the main hormone of the pineal
gland, is likely to interact with ion channels at the cell
membrane and influence the membrane potential (Wanecek
and Klein, 1992; Pieri et al., 1998; Jiang et al., 1995;
Oreslock, 1984; Pioli et al., 1993). An inhibitory effect of
melatonin has also been observed on the proliferation of
Received for publication 15 April 1999 and in final form 1 December 2000.
Address reprint requests to Dr. Rezso Gaspar, Jr., Department of Biophys-
ics and Cell Biology, University Medical School of Debrecen, Nagyerdei
krt. 98, Debrecen H-4012, Hungary. Tel.: 36-52-412-623; Fax: 36-52-623;
E-mail: gaspar@jaguar.dote.hu.
Zolta´n Varga and Gyo¨rgy Panyi are equally considered as first author.
© 2001 by the Biophysical Society
0006-3495/01/03/1280/18 $2.00
1280 Biophysical Journal Volume 80 March 2001 1280–1297
human lymphocytes and lymphoid cells (Persengiev and
Kyurkchiev, 1993; Vijayalaxmi et al., 1996).
In view of these observations and the involvement of
Kv1.3 channels in lymphocyte activation, the effect of ex-
tracellular melatonin has been studied on the Kv1.3 chan-
nels of human peripheral blood T lymphocytes by the patch-
clamp method.
Due to the possible role of melatonin in immunological
processes (see Liebmann et al., 1997, for review) our initial
goal was to find a detectable interaction of melatonin with
ion channels of T cells at its physiological concentration
(200 pM; Liebmann et al., 1997). However, observable
effects were only seen at concentrations several orders of
magnitude higher than the physiological range. The effec-
tive concentration range was found to be similar to that
applied in the studies demonstrating the influence of mela-
tonin on the membrane potential and proliferation of lym-
phocytes. Although this renders the physiological relevance
of this interaction unlikely, the unusual characteristics of the
blocking mechanism are worth investigating.
Here we show that melatonin, an amino acid derivative,
blocks Kv1.3 channels in a reversible manner. During the
block the drug-channel interaction is characterized by a 4:1
binding stoichiometry and not by a simple pore-blocking
mechanism. Part of this work has been published in abstract
form (Varga et al., 1999).
MATERIALS AND METHODS
Cells
Heparinized human peripheral venous blood was obtained from healthy
volunteers. Mononuclear cells were separated by Ficoll-Hypaque density
gradient centrifugation. Collected cells were washed twice with Ca2 and
Mg2 free Hanks’ solution containing 25 mM HEPES (pH 7.4). Cells were
cultured in a 5% CO2 incubator at 37°C in 24-well culture plates in
RPMI-1640 supplemented with 10% FCS (Hyclone, Logan, UT), 100 U/l
penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine at 0.5 106/ml
density for 3–4 days. The culture medium also contained 2.5 or 5 g/ml
phytohemagglutinin A (PHA-P, Sigma-Aldrich Kft, Budapest, Hungary) to
increase K channel expression (Deutsch et al., 1986, 1991).
Cytotoxic murine T cells (CTLL-2) were transiently co-transfected with
plasmids encoding a mutated (pRc/CMV/H399Y) Kv1.3 channel along
with a Ccd4neo plasmid (gifts from Dr. Carol Deutsch, University of
Pennsylvania, Philadelphia, PA), containing the gene for human mem-
brane-surface CD4, at a molar ratio of 5:1 or 8:1 [32 or 48 g/ml total
DNA] using electroporation (Deutsch and Chen, 1993). CTLL-2 cells were
cultured in RPMI-1640 supplemented with 10% FBS (Hyclone, Logan,
UT), 2 mM sodium pyruvate, 10 mM HEPES, 4 mM L-glutamine, 50 M
2-mercaptoethanol, and 100 CU/ml IL-2. Before transfection, cells were
cultured for 24 h in fresh medium and collected in the logarithmic phase of
growth. After harvesting, cells were suspended in Hanks’ 20 mM HEPES
balanced salt solution (pH  7.23) at 2  107 cells/ml, and the appropriate
mixture of DNA was added to the cell suspension. This suspension was
transferred to electroporation cuvettes (400 l/cuvette, 4 mm electrode
gap), kept on ice for 10 min, and then electroporated using a BTX
electroporator (San Diego, CA) with settings previously determined to give
50% viability at 24 h posttransfection (725 V/cm, 2200 F, 13 ). The
resultant time constants were 24–25 ms. Cells were incubated for an
additional 10 min on ice, and transferred back to culture medium (0.5 
106 cells/ml) supplemented with 5 mM sodium butyrate (at 37°C, 5%
CO2). Cells were used for electrophysiology between 8 to 16 h after
transfection.
Electrophysiology
Whole-cell and single-channel measurements were carried out using Axo-
patch-200 and Axopatch-200A amplifiers connected to personal computers
using Axon Instruments TL-1–125 and Digidata 1200 computer interfaces,
respectively. For data acquisition and analysis the pClamp6 software
package (Axon Instruments Inc., Foster City, CA) was used. T lympho-
cytes and CD4 CTLL-2 cells were selected for current recording by
incubation with mouse anti-human CD2 (Becton-Dickinson, San Jose, CA)
and mouse anti-human CD4 antibodies (0.5 g/106 cells, AMAC, West-
brook, ME), respectively, followed by selective adhesion to petri dishes
coated with goat anti-mouse IgG antibody (Biosource, Camarilo, CA), as
previously described by Matteson and Deutsch (1984) and Deutsch and
Chen (1993). Dishes were washed gently five times with 1 ml normal
extracellular bath medium (see below) before the patch-clamp experiments.
Standard whole-cell patch-clamp techniques were used, as described pre-
viously (Matteson and Deutsch, 1984). Pipettes were pulled from GC 150
F-15 borosilicate glass capillaries (Clark Biomedical Instruments, Pang-
bourne, UK) in two stages and fire-polished to give electrodes of 2–3 M
resistance in the bath. The normal bath solution was (in mM): 145 NaCl,
5 KCl, 1 MgCl2, 2.5 CaCl2, 5.5 glucose, 10 HEPES (pH 7.35, 305 mOsm).
For CTLL-2 cells the bath solution also contained recombinant interleu-
kin-2 (8.3 ng/ml). The pipette solution was (in mM): 140 KF, 11 K2EGTA,
1 CaCl2, 2 MgCl2, and 10 HEPES (pH 7.20, 295 mOsm).
Test substances
Melatonin (Sigma-Aldrich Kft) stock solution was prepared in DMSO (200
mM). Bath solutions with different melatonin concentrations were prepared
freshly before the experiments. Appropriate control bath solutions con-
tained equal DMSO concentration to the test solution. The normal bath
solution prepared this way was referenced as control in the paper unless
stated otherwise (see below). The maximal DMSO concentration was 5%
v/v. Different TEA-Cl solutions were prepared by equimolar substitution of
NaCl with TEA-Cl. In high K solution, NaCl was completely substituted
by KCl (150 mM KCl final concentration). Charybdotoxin (Alamone Labs
Ltd., Jerusalem, Israel) was dissolved in normal bath solution supple-
mented with 0.1 mg/ml bovine serum albumin (Sigma-Aldrich Kft).
Bath perfusion with different test solutions was achieved using a grav-
ity-flow perfusion setup with eight input lines and a PE10 polyethylene
tube output tip with flanged aperture to reduce turbulence of the flow.
Solutions were applied in an alternating sequence of control and test
solutions unless stated otherwise. Excess fluid was removed continuously
from the bath.
FIGURE 1 The chemical structure of melatonin.
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Data analysis
Before analysis whole-cell current traces were corrected for ohmic leak and
digitally filtered (3-point boxcar smoothing). Nonlinear least-squares fits
were done using the Marquardt-Levenberg algorithm. Fits were evaluated
visually by the residuals and the sum of squared differences between the
measured and calculated data points.
Single-channel traces were digitally filtered using 400 Hz Gaussian
filtering. Traces that contained no channel openings were averaged and this
average current was subtracted from each trace to subtract capacitive and
leakage currents. Short regions at the beginning of traces were not included
in the analysis to leave out noisy multiple openings. All-points histograms
were fitted with the sum of Gaussian distributions using the least-squares
technique.
Statistical comparisons were made using Student’s t-test, and when
appropriate, paired t-test or ANOVA at p  0.05. For all experiments the
standard error of the mean (SE) is reported.
RESULTS
Block of Kv1.3 channels by melatonin
Fig. 2 illustrates that upon depolarization to 40 mV test
potential from a holding potential of 120 mV human T
lymphocytes display outward whole-cell currents under the
applied experimental conditions. This quickly activating
and slowly inactivating current has been identified as po-
tassium current flowing through voltage-gated ion channels
designated Kv1.3 (Matteson and Deutsch, 1984; Decoursey
et al., 1984). The amplitude of the potassium current is
considerably reduced during perfusion of the bath with
extracellular solution containing 2 mM melatonin, as shown
in Fig. 2 A. In addition, the rate of inactivation of the
whole-cell current is also increased by melatonin. Both the
amplitude of the whole-cell current and the inactivation
time constant returned to the control value when the extra-
cellular bath was reperfused with drug-free bath solution
(apart from a negligible inherent acceleration of inactivation
with time after achieving whole-cell configuration).
Development of and recovery from current inhibition was
studied using short (50-ms) pulses to 40 mV (Fig. 2 B)
applied every 60 s. This pulse rate did not cause cumulative
FIGURE 2 Melatonin reversibly blocks Kv1.3 channels. (A) Whole-cell
K currents of a human peripheral T lymphocyte recorded during 2-s-long
test pulses to 40 mV from a holding potential of 120 mV. Test pulses
were applied every 90 s. The bath was perfused with (1) control solution,
(2) a solution containing 2 mM melatonin, (3) control solution again.
During the experiment excess fluid was removed by continuous suction.
Sampling and low-pass filter frequencies were 2000 and 1000 Hz, respec-
tively. Off-line leak subtraction and 3-point boxcar smoothing were ap-
plied. (B) Whole-cell peak currents of a human T lymphocyte during the
administration and washout of 1.5 mM extracellular melatonin. Test pulses
to 40 mV (50 ms duration) were applied every 60 s. Continuous perfu-
sion was applied with control solution before the down arrow, with the
same solution containing 1.5 mMmelatonin after the down arrow, and with
control fluid again after the up arrow. Off-line leak subtraction and 3-point
boxcar smoothing were used. Sampling and low-pass filter frequencies
were 20 and 5 kHz, respectively. (C) The same experimental arrangement
as for B but 1-s-long test pulses were applied to 40 mV every 60 s.
Off-line leak subtraction and 3-point boxcar smoothing were used. Sam-
pling and low-pass filter frequencies were 2000 and 1000 Hz, respectively.
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inactivation of Kv1.3, indicated by constant peak currents in
the control solution. Switching to melatonin (1.5 mM) con-
taining bath solution during the 60-s interpulse interval
caused an instant reduction of the peak current in the first
trace following the switch, and this reduction was constant
for subsequent pulses in the presence of 1.5 mM melatonin,
i.e., current reduction did not accumulate. Switching back to
normal bath solution resulted in an instant recovery of the
current.
Fifty-millisecond-long depolarization to 40 mV caused
very little inactivation of Kv1.3. Thus we repeated the same
pulse/perfusion protocol using 1-s-long depolarizations to
40 mV (Fig. 2 C), which inactivate 95% of Kv1.3 (Fig.
2 A). However, this did not change the pattern of current
reduction (compare Fig. 2, B and C). Repeated pulses every
60 s gave constant peak currents before the application of
the drug and current reduction did not accumulate from
pulse to pulse in the continuous presence of melatonin.
Moreover, there was no difference in the reduction of the
current amplitude when using short (50-ms) or long (1000–
2000-ms) depolarizing pulses at regular time intervals. The
ratio of peak currents recorded in the presence and absence
of 1.5 mM melatonin were 0.52 	 0.02 and 0.50 	 0.02
(n  16 and 9, p  0.28) for short and long pulses,
respectively (see also Fig. 2, B and C). Thus, reduction of
the peak current was independent of the pulse protocol
applied.
Reduction of the peak current in the presence of melato-
nin may be attributed to either an altered reversal potential
of the current or to the reduction of the whole-cell K
conductance. To differentiate between these possibilities we
determined the reversal potential of the current in the pres-
ence and absence of melatonin using standard tail current
analysis (see below). Currents reversed at 82 	 0.6 mV
and82.8	 1.5 mV in control solution and in the presence
of 1.5 mM melatonin, respectively (n  3, p  0.75). Thus,
current inhibition should be the consequence of a reduction
in the whole-cell conductance in the presence of melatonin.
Both the voltage dependence of steady-state activation
and inactivation were altered slightly by melatonin (Fig. 3,
FIGURE 3 Effect of melatonin on the steady-state parameters of volt-
age-dependent gating of Kv1.3. (A) Voltage-dependence of steady-state
activation of the K current in a human T-lymphocyte in the presence and
absence of melatonin. The cell was held at120 mV holding potential and
depolarized to the indicated test potentials for 40 ms every 50 s. Peak
whole-cell conductance (G(V)) at each test potential was calculated from
the peak current (Ip) at test potential V and the reversal potential (Er). This
latter quantity was determined independently from tail current experiments
(see text). The G(V) values were normalized for the maximum conductance
and plotted (filled circles) as a function of test potential along with the
best-fit Boltzmann function (normalized conductance  1/(1  exp[(V 
V1⁄2,a)/sa]), where V is the test potential, V1⁄2,a is the midpoint, and sa is the
slope of the function, solid line). In control solution V1⁄2,a33.5 mV and
sa  6.4 mV were obtained for this cell. Continuous application of bath
solution containing 2 mM melatonin changed the slope of the Boltzmann
function (sa  10.5 mV) but caused a negligible shift in the midpoint
(V1⁄2,a  36.1 mV). Normalized conductances in the presence of mela-
tonin are shown with empty circles. (B) Voltage-dependence of steady-
state inactivation of the K current in a human T-lymphocyte in the
presence and absence of melatonin. The applied prepulse-test pulse se-
quence was formed by a 150-s-long prepulse and a subsequent test pulse to
50 mV for 50 ms where the peak currents were measured. In every other
prepulse-test pulse sequence the prepulse potential was set to 140 mV to
avoid artifacts arising from gradual rundown of the current. The extent of
steady-state inactivation was expressed as the ratio of peak currents re-
corded after a given prepulse potential (I) to the peak current preceded by
140 mV prepulse potential (I0) in the previous pulse sequence. This ratio
(I/I0) is plotted as a function of prepulse potential for a T cell. Filled circles
indicate points acquired in control external solution while hollow circles
indicate those acquired in an external solution containing 1.5 mM mela-
tonin. The midpoint of the Boltzmann function (see above) fitted to the
points was shifted toward the negative potentials by melatonin (V1⁄2,i 
60.3 mV for control and V1⁄2,i67.5 mV in the presence of melatonin).
At the same time the slope of the function was also slightly affected, si 
4.5 mV and si 4 mV were obtained for control and in the presence of 1.5
mM melatonin, respectively.
Melatonin Binding to Kv1.3 1283
Biophysical Journal 80(3) 1280–1297
A and B) as reported by the parameters of Boltzmann
functions fitted to the normalized conductance versus test
potential and remaining fraction of current (I/I0) versus
prepulse potential relationships, respectively (see figure leg-
ends for details). The midpoint of voltage dependence of
steady-state activation (V1⁄2,a) in control solution was
27.9 	 1 mV. This value did not change significantly in
the presence of 2 mM melatonin (V1⁄2,a  28.1 	 3.2 mV,
n  5, p  0.95). The slope factor (sa) however changed
from sa  9.6 	 0.7 mV in control solution to sa 
15.7 	 2 mV in the presence of 2 mM melatonin. The
midpoint of voltage dependence of steady-state inactivation
(V1⁄2,i) was shifted by melatonin from V1⁄2,i  58.3 	 1.8
mV (control) to V1⁄2,i  67.2 	 2.2 mV (1.5 mM mela-
tonin, n  5, p  0.02). This shift in the V1⁄2,i was not
FIGURE 4 Voltage dependence of melatonin block studied by tail cur-
rent analysis. (A) Tail currents of a human T cell. Channels were activated
by a 5 ms pulse to 50 mV, then the voltage was stepped back to values
ranging from 100 to 40 mV in 20-mV steps and tail currents were
recorded. Pulses were separated by 60-s intervals at a holding potential of
120 mV. Sampling rate was changed from 50 to 16.6 kHz after the 5-ms
pulse. Data were filtered at 5 kHz. P/7 leak subtraction was applied with
subepisodes preceding the recorded sweep. (B) The effect of melatonin on
the open channel current-voltage relationship. Instantaneous tail current
amplitudes were determined at the indicated test potentials in the absence
(filled circles) and in the presence (open circles) of melatonin (1.5 mM).
The relationship was linear in both cases. Inset: Voltage dependence of
melatonin block. The ratio of the peak tail current measured in the presence of
1.5 mM melatonin to that measured in control solution was calculated at each
test potential in the 60 to 40 mV range. The average slope of the straight
lines fitted to the data points was 1.69  104 	 9.1  105 mV1.
FIGURE 5 Block of inward and outward currents by melatonin. (A) A
human peripheral blood T-lymphocyte was held at 120 mV and currents
were recorded at depolarizations to either40 (traces 1 and 3) or30 mV
(traces 2 and 4). These test potentials resulted in outward and inward
currents, respectively, since the extracellular solution contained 150 mM
K. Traces 1 and 2 were recorded in drug-free solution, while current
traces 3 and 4 were recorded in the presence of 1.5 mM melatonin. The
sampling rate was 10 kHz, filter was set to 5 kHz. (B) The bars show the
remaining fraction of current in the presence of 1.5 mM melatonin at test
potentials 30 mV (open bar) and 40 mV (hatched bar). The remaining
fraction of the current (I/I0) was calculated as the ratio of peak currents in
the presence (I) and absence (I0) of melatonin (error bars indicate SE, n  3).
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associated with a significant change in the slope factor
(control: si 4.1	 0.7; melatonin: si 5.1	 0.6 mV, n
5, p  0.11).
Regardless of the change in V1⁄2,i and sa, the voltage
dependence of normalized activation and steady-state inac-
tivation functions of control and melatonin-treated cells
assume the same values at holding potentials more negative
than 120 mV and test potentials more positive than 40
mV. Thus, melatonin-induced changes in sa and V1⁄2,i set a
membrane potential window for voltage protocols where
reduction of the peak currents is attributed to the block of
potassium channels by the drug. Accordingly, this voltage
range was used in this study (including data shown previ-
ously in Fig. 2).
To determine whether the change in sa is due to voltage-
dependent block by melatonin we measured the open chan-
nel current-voltage relationship with or without melatonin
in the bath solution. Because block equilibration is very fast
(see below in Fig. 6) instantaneous tail currents at each
potential should represent the fraction of the channels not
blocked by melatonin.
Fig. 4 shows the recorded tail currents (A) and the instan-
taneous current voltage relationship in the absence and
presence of 1.5 mM melatonin (B). Some rectification was
observable below 60 mV for both cases, but at potentials
more positive than 60 mV the current-voltage relation-
ships were perfectly linear with r2  0.999 	 0.0003 and
0.997 	 0.0010 for control and after melatonin treatment
(1.5 mM), respectively (n  5). The ratios of instantaneous
tail current amplitudes measured with 1.5 mM melatonin in
the bath to those measured in control extracellular solution
were calculated and plotted as a function of test potential
(inset to Fig. 4 B) to investigate the voltage dependence of
melatonin block. Straight lines were fitted to the points
yielding an average slope and intercept of 1.69  104 	
9.1  105 mV1 and 0.52 	 0.01 (n  5), respectively.
The negligible slope implies a lack of voltage dependence
of melatonin block.
Moreover, the degree of block was independent of the
direction of current flow. Fig. 5 shows currents recorded in
symmetrical K (150 mM) solution in the presence and
FIGURE 6 The effects of melatonin on single-channel currents of
Kv1.3. (A) An outside-out patch was pulled from a human T-lymphocyte.
Traces were recorded during depolarizing pulses to 0 mV from a holding
potential of 120 mV. Pulses were applied every 10 s and lasted for 1 s.
Data were recorded at 5 kHz sampling rate and low-pass filtering was
applied at 500 Hz. Upper trace: bath perfusion with control external
solution. Lower trace: bath perfusion with external solution containing 5
mM melatonin. (B and C) All-points histograms were generated using
0.0157 pA bin-width. Superimposed continuous lines are the best fits to the
histograms with the sum of two normal distributions. The fitted parameters
in control solution (B) are 1 0.019 pA, 1 0.106 pA, 2 0.748 pA,
2  0.272 pA, where n and n are the mean and standard deviation of
the nth component, respectively. The weight of the first component (non-
conducting state) is 0.533. The fitted parameters in the presence of 5 mM
melatonin are 1 0.026 pA, 1 0.086 pA, 2 0.360 pA, 2 0.216
pA. The weight of the first component is 0.746.
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absence of melatonin. At 30 and 40 mV test potentials
the currents are inward and outward, respectively (Fig. 5 A).
The ratios of peak currents measured in the presence and
absence of melatonin at different membrane potentials are
shown in Fig. 5 B. The remaining fraction of the current in
the presence of 1.5 mM melatonin was the same regardless
of the direction of current flow (n  3, p  0.31, paired
t-test).
Single-channel amplitude is
reduced by melatonin
Fig. 6 shows single-channel currents recorded from an out-
side-out-patch in the absence and presence of melatonin.
The all-points histogram generated from the trace recorded
at 0 mV in normal bath solution peaks at  0.75 pA (
0.27 pA) corresponding to 9.1 pS conductance, in agree-
ment with the literature (Lee et al., 1992). Extracellular
FIGURE 7 Inactivation of the K current in the presence of melatonin.
(A) Whole-cell K currents of a human peripheral T lymphocyte recorded
during 2-s-long test pulses to 40 mV from a holding potential of 120
mV. Test pulses were applied every 90 s. The bath was perfused with
control solution (1), a solution containing 0.5 mM (2), 1.0 mM (3), and 2.0
mM melatonin. During the experiment excess fluid was removed by
continuous suction. Sampling and low-pass filter frequencies were 1000
and 500 Hz, respectively. Superimposed dashed lines are the best-fit single
exponential functions to the decay of the currents: I(t)  A  exp(t/) 
C, where A and C are the amplitudes of the inactivating and noninactivating
components, respectively, and  is the time constant. The values of  were
189.3 ms (1), 114.0 ms (2), 76.3 ms (3), and 45.2 ms (4). (B) The ratio of
inactivation time constants of whole-cell K currents in the presence (b)
and absence (c) of melatonin were plotted as function of melatonin
concentration. Error bars indicate SE (n  2–4).
FIGURE 8 Recovery from inactivation is not changed by melatonin. (A)
A human T-lymphocyte in whole-cell clamp was held at 120 mV and a
pair of test pulses (1 s duration) to 40 mV was applied separated by a
6.5-s interpulse interval (ipi). The peak currents during the first pulse (P1),
during the second pulse (P2), and the current at the end of the first pulse
(SS1) were measured. From these data fractional recovery was calculated as
in the text. The membrane was held at 120 mV during the ipi. Sampling
frequency was 1 kHz. (B) Fractional recovery of potassium current as a
function of ipi in control extracellular solution (filled circles) and in an
external solution containing 2 mM melatonin (open circles). Points were
fitted with a single rising exponential function (see text). The solid and
dashed lines represent the best fit to the data obtained in control conditions
and in the presence of melatonin, respectively. The corresponding time
constants for recovery from inactivation were 15.2 s and 13.9 s for control
and in the presence of melatonin, respectively.
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addition of melatonin decreased the amplitude of single-
channel currents (Fig. 6 C). Average current amplitude was
reduced to 77.7 	 0.5% of the control by 1.5 mM and to
58.3 	 6.3% by 5 mM melatonin. Our interpretation of the
reduction in the average amplitude is that the transition
between the conducting (no melatonin bound) and the non-
conducting (melatonin bound) states is very fast so that
blocked periods are too brief to be resolvable using our
recording apparatus. Instead, an average of the currents
from the open and blocked periods is recorded, similarly to
the block of Shaker K channels by TEA (Spruce et al.,
1987). In this case both the on and off rates of the drug must
be fast as it is illustrated in Fig. 2, B and C.
Effect of melatonin on the inactivation properties
of Kv1.3 current
Fig. 2 A shows that besides blocking the potassium current
melatonin also increases the rate of current inactivation. We
studied the dose dependence of this effect. The kinetics of
inactivation of the whole-cell Kv1.3 current was character-
ized by the time constant of a single-exponential function
fitted to the data points. In control solution the resulting
time constant was c  188 	 7 ms (n  7) determined at
40 mV test potential. At all melatonin concentrations the
current decay could well be fitted with a single-exponential
function (Fig. 7 A, see legend). Fig. 7 B shows that increas-
ing concentrations of melatonin sped inactivation in a dose-
dependent manner, manifesting in a decreased ratio of b/c
with increasing drug concentration, where b and c are the
inactivation time constants in the presence and absence of
the drug, respectively.
Fig. 7 suggests that the concentration-dependent increase
in current inactivation is the result of faster inactivation of
melatonin-bound channels. Inactivated channels with bound
melatonin might recover at different rates from inactivation
as compared to control, thereby indicating the binding of
melatonin to the inactivated channels. This was tested in the
experiments described below.
The kinetics of recovery from inactivation was measured
by a conventional protocol using pulse pairs (Fig. 8 A). One
pulse pair consisted of 1-s-long test pulses (40 mV) sep-
arated by various interpulse intervals (ipi) ranging from 1 to
80 s at  120 mV. The 1-s-long test pulse was enough to
inactivate 95% of the current. Time between pulse pairs
was 120 s at a holding potential of 120 mV to allow full
recovery of the channels. The fraction of channels recovered
(FR) from the inactivated state at any ipi was calculated
using the following formula: FR  (P 2  SS1)/(P1  SS1),
where P1 and P2 are peak currents detected during the first
and the second pulses in the pair, respectively, and SS1 is the
amplitude of the current at the end of the first pulse. FR
calculated using this formula is free from contamination by
any nonspecific conductance, as well as different levels of
current at the end of the first depolarization. We determined
the time constant for recovery from inactivation by plotting
FR as the function of interpulse interval and fitting a single-
exponential function: FR(ipi) 1 exp(ipi/) to the data
points (Fig. 8 B). The time constants for recovery from
inactivation were 11.2 	 2.1 s and 11.0 	 2.1 s for control
and in the presence of 2 mM melatonin, respectively. The
difference was not statistically significant (n  3, p  0.82,
paired t-test).
Peak currents represent equilibrium block of
potassium current
Fig. 2, B and C show that reduction of the peak current is
instantaneous after the start of the perfusion regardless of
the pulse protocol applied. However, these experiments did
not exclude the possibility of slow equilibration of the block
in the closed state of the channel. This possibility was tested
in the next experiment (Fig. 9). We compared the percent-
age of current block in cases when depolarizing pulses were
regularly applied following the start of the application of
melatonin (first application of melatonin in Fig. 9, protocol
A) with those in which channels were kept closed for
several minutes during the application of melatonin and
then depolarized to measure the current (second application
of melatonin in Fig. 9, protocol B). The reduction in the
peak currents was essentially the same, 50% and 47%,
calculated from protocols A and B, respectively.
In summary, the above experiments shown in Figs. 2–9
support the idea that a use-dependent block can be excluded
and that the reduction of the peak currents reflects equilib-
FIGURE 9 Closed-state association of melatonin to Kv1.3. Whole-cell
peak currents recorded in a human T lymphocyte during test pulses to 40
mV from a holding potential of 120 mV. Horizontal bars indicate the
duration of bath perfusion with a solution containing 1.5 mM melatonin.
Test pulses were applied every 60 s except the gap between 12 and 16 min
(between vertical lines) where 1.5 mM melatonin was already applied but
test pulses were suspended. Pulse duration was 50 ms, sampling frequency
20 kHz.
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rium block of the channels under the applied conditions. A
possible explanation for the reduced peak currents in the
presence of melatonin is that it binds to the closed state of
the channels and remains bound once the channels open.
Alternatively, it binds to the open state at much higher rates
that can be resolved in patch-clamp experiments, similarly
to the action of TEA. Furthermore, the increased inactiva-
tion rate of the current can be a consequence of modulation
of inactivation by binding of melatonin.
Four available binding sites for melatonin
The blocking effect of melatonin was dose-dependent, with
a half-blocking concentration of 1.5 mM. A theoretical
curve based on 1:1 channel/melatonin stoichiometry (model
I) gave a poor fit to the measured points at various concen-
trations (Fig. 10 A), thus we looked for alternative models.
Because Kv1.3 channels are made up of four identical
subunits, the assumption that four independent melatonin
binding sites exist on each channel seemed logical.
Even in this case several alternatives had to be consid-
ered. First, a single melatonin molecule binding to any of
the four sites is sufficient to block the channel (model IIa).
Second, all four sites must be occupied by melatonin to
block the channel, but unitary conductance is not affected
when only one, two, or three molecules are bound (model
IIb). Third, each melatonin molecule binding to a site on the
channel decreases the single-channel conductance in a step-
wise fashion (model IIc).
The probability that a melatonin molecule binds to an
individual binding site (1:1 stoichiometry) at melatonin
concentration [m] is p  [m]/([m]  Kd), where Kd is the
dissociation constant, i.e., the melatonin concentration at
which half of the binding sites are occupied (Hille, 1992).
Accordingly, the probability that no melatonin molecule
binds to it is q  1  p  Kd/([m]  Kd).
Dose-response functions for the three different models
can be constructed using the binomial distribution (Mac-
FIGURE 10 Comparison of the various models of melatonin binding.
Peak whole-cell currents in human T-lymphocytes were measured at de-
polarizing test pulses to 40 mV from a holding potential of 120 mV.
The unblocked fraction of the peak current was calculated at different
melatonin concentrations as I/I0, where I0 and I were the peak currents
measured in the control solution and in solutions containing different
concentrations of melatonin, respectively. On each panel the measured
points and the SE (n  3–11) are displayed with two fitted functions
corresponding to different models. The solid line on each panel represents
the model in which the binding of one melatonin molecule to any of the
four binding sites on the channel is enough to block the channel (model
IIa). The dashed lines represent the other models: (A) one binding site per
channel, one bound molecule blocks the channel (model I); (B) four
binding sites per channel, all four must be occupied to block the channel
(model IIb); (C) four binding sites per channel, each molecule binding to
the channel decreases the unitary current amplitude by one-fourth of the
original amplitude (model IIc).
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Kinnon, 1991). In this case the probability that of the n  4
independent sites exactly k are occupied by melatonin mol-
ecules is
Pk
n!
k!
n k! p
kqnk (1)
If a single melatonin molecule is sufficient to block the
channel, then the channel conducts only if none of the sites
is occupied. The probability of this event is q4  [ Kd/([m]
 Kd) ]4, which gives the remaining fraction of the current
at melatonin concentration [m] in a whole-cell measure-
ment. However, if all four sites must be occupied for the
block to occur, then the fraction of unblocked channels is
1  p4  1  [[m]/([m]  Kd)]4.
The theoretical functions derived from the various mod-
els are compared in Fig. 10. The best fit to the experimental
data was obtained with model IIa, therefore this model
(solid line) is presented in comparison with each of the other
models (dashed line) on panels A–C. In Fig. 10 A the 1:1–
binding site to channel stoichiometry is compared with
model IIa. In Fig. 10 B both models assume four binding
sites per channel, but in one of the models one melatonin
molecule is enough to block the channel (IIa), in the other
four molecules are required to do so (IIb). Kd values for
individual binding sites obtained from the fits were 8.11
mM and 0.26 mM for models IIa and IIb, respectively.
The simplest function representing model IIc is based on
the assumption that each melatonin molecule that binds to
the channel decreases the current amplitude by one-fourth
of the original amplitude. Thus, the current amplitude is
reduced to 0.75, 0.5, or 0.25 times of the maximum ampli-
tude when one, two, or three melatonin molecules are bound
to the channel, respectively, and four bound molecules are
required to block the channel completely. In this case the
whole-cell current is given by the binomially weighted sum
of five terms:
I
Io
 
k0
4
Pk
4 k
4 , (2)
where k is the number of binding sites per channel occupied
by melatonin. The Kd value for the individual binding sites
is 1.72 mM for this model. The fitted function based on this
FIGURE 11 Simultaneous application of melatonin from the intracellu-
lar and extracellular sides. Whole-cell K currents of human T-lympho-
cytes are displayed (1) before and (2) after the extracellular application of
1.5 mM melatonin using (A) control internal solution and (B) internal
solution containing 1.5 mMmelatonin. Other experimental conditions were
the same as for Fig. 2. (C) Remaining fraction of current was calculated as
I/I0, where I0 is the peak of the current recorded with no melatonin in the
bath and I is the peak during the extracellular application of 1.5 mM
melatonin. The open and hatched bars show the remaining fraction of
current recorded with normal and melatonin (1.5 mM) supplemented
pipette filling solutions, respectively. Extracellular application of 1.5 mM
melatonin resulted in the same fractional decrease in current amplitude
when the pipette solution contained 1.5 mM melatonin or was melatonin-
free (p  0.95).
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model is also compared with model IIa in Fig. 10 C and
clearly gives a worse fit to the measured data.
The comparison of the dose-response functions based on
their goodness of fit reveals that the model that best de-
scribes the experimental observations is the one in which
the binding of a single melatonin molecule to any of the four
binding sites on the channel blocks the channel (model IIa).
The goodness of fit was assessed by calculating the residual
sum of squares for each curve. In principle, the model with
the lowest residual sum of squares gives the best fit if the
number of degrees of freedom (i.e., number of data points
minus the number of parameters) is the same for all models.
In our case this condition was fulfilled since the number of
data points was constant and each fitted function had one
free parameter, Kd (Motulsky and Ransnas, 1987). The
residual sum of squares were 0.036, 0.006, 0.021, and 0.07
for models I through IIc, respectively.
Melatonin acts from the extracellular side
Several effects of melatonin can be attributed to its ability to
cross biological membranes (Costa et al., 1995). Therefore
we wanted to determine whether it binds to Kv1.3 from the
intracellular or extracellular side. The fact that both extra-
cellular blocking and washout occur very quickly suggests
that melatonin binds directly from this side. We tested this
hypothesis by introducing melatonin to the pipette solution
and assessing the block of potassium current by extracellu-
lar melatonin applied in the same concentration (1.5 mM) as
in the pipette solution. This way, if melatonin were to act
from the inside it would block the appropriate fraction of
channels, and the extracellularly applied melatonin should
have no further effect on the current. However, if melatonin
acts from the outside extracellular melatonin should affect
the current the same way it would when using regular
pipette solution. The results of these experiments are sum-
marized in Fig. 11. The results show no significant differ-
ences in the reduction of current amplitudes between mea-
surements with or without intracellular melatonin. Thus,
these results prove that melatonin block occurs from the
extracellular side of the membrane.
Simultaneous occupancy of binding sites by
melatonin and ChTx
ChTx blocks potassium channels by simply occluding the
pore. Binding of ChTx and another pore blocker, TEA, to
the pore of voltage- and calcium-activated potassium chan-
nels is mutually exclusive, indicating overlapping binding
sites for ChTx and TEA (Miller, 1988; Goldstein and
Miller, 1993). Similarly, we examined the relationship of
ChTx and melatonin binding to Kv1.3. The protocol applied
is shown in Fig. 12 A. The remaining fractions of whole-cell
peak currents were determined in the presence of melatonin,
FIGURE 12 Effects of TEA and ChTx on melatonin binding to Kv1.3
channels. (A) Peak whole-cell currents in a human peripheral blood T-
lymphocyte are plotted as a function of trace number in a series of identical
depolarizations. The cell was held at 120 mV for 50 s between depolar-
izing pulses to 40 mV lasting for 50 ms. The solutions used for the
perfusion of the external bath are indicated by the bar on the lower part of
the figure: control solution (empty bar), 1.5 mM melatonin (left-hatched),
simultaneous presence of 1.5 mM melatonin and 1.5 nM ChTx (cross-
hatched), and 1.5 nM ChTx (right-hatched). The remaining fractions of
currents determined from this experiment were RFm 0.533, RFs 0.122,
RFChTx  0.25, and RFmChTx  0.488. (B) Comparison of competition
models. The binding affinity of melatonin was studied at various concen-
trations of TEA (bottom x axis) and ChTx (top x axis). The dash-dot-dot
line represents the model in which melatonin and the other blocker bind
independently leaving, the Kd of melatonin unaffected (see text for details).
The solid line represents the competition model in which melatonin and the
other blocker cannot be present on the same channel simultaneously. Each
data point represents the mean 	 SE (n  3–4) of the relative dissociation
constants calculated from the measured data at the indicated TEA (circles)
and ChTx concentrations (triangles). Relative Kd was calculated as the
ratio of apparent Kd of melatonin in the presence of TEA or ChTx and its
real Kd in the absence of TEA and ChTx. Apparent Kd was determined
from RFmChTx and RFmTEA (see text for details) based on model IIa.
The binding affinity of melatonin to wild-type channels is influenced by
TEA (circles) but not by ChTx (triangles).
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in the presence of ChTx, and during simultaneous admin-
istration of the two compounds.
The remaining fraction of the whole-cell current in the
simultaneous presence of both ChTx and melatonin can be
written as RFs  1  [P(ChTx)  P(m)  P(ChTx  m)],
where P(ChTx) is the probability of ChTx block, P(m) is the
probability of melatonin block, and P(ChTx  m) is the
probability that both compounds are bound to the channel
simultaneously. If the binding of one has no effect on the
binding of the other, then P(ChTx  m)  P(ChTx) 
P(m), since the probability of independent events occurring
simultaneously is the product of their individual probabili-
ties. In the absence of ChTx the application of melatonin
would result in a remaining current fraction of RFm  1 
P(m). If both ChTx and melatonin are present and the
current in the presence of ChTx alone (RFChTx) is taken as
control, the remaining fraction of the current would be
RFmChTx  RFs/RFChTx  (1  [P(ChTx)  P(m) 
P(ChTx)  P(m)])/(1  P(ChTx)). Comparison of the
expressions for RFm and RFmChTx reveals that the extent
of current reduction by melatonin would not depend on
whether ChTx is present. Therefore, the apparent Kd value
for melatonin calculated from RFmChTx would be constant
at all ChTx concentrations and equal to its real Kd value,
calculated from RFm. This model is represented on Fig. 12
B by the dash-dot-dot line.
By using 1.5 mM melatonin concentration and increasing
concentrations of ChTx, apparent Kd values were deter-
mined experimentally, and the ratio of the apparent and real
Kd values was plotted on the graph as a function of ChTx
concentration. The data points are scattered around the
dash-dot-dot line, indicating independent binding of mela-
tonin and ChTx to the channel. This indicates that the binding
sites for these two molecules are not overlapping, melatonin
and ChTx can bind simultaneously to the channel.
Melatonin interacts with TEA binding to Kv1.3
Melatonin speeds C-type inactivation of Kv1.3 (see Figs. 2
A and 7). Inactivation kinetics of Shaker potassium channels
is very sensitive to the nature of amino acid side chains and
their physical state at position 399 (Lo´pez-Barneo et al.,
1993). Amino acids at the same position are responsible for
creating a binding site for extracellular TEA (Heginbotham
and MacKinnon, 1992; Kavanaugh et al., 1991). We have
monitored this region of the channel through the TEA
binding site by characterizing the interaction of melatonin
and TEA binding to their respective receptors.
By using the same experimental protocol as for the pre-
vious section, we have expressed the apparent Kd value for
melatonin from RFmTEA  RFs/RFTEA, where RFs is the
remaining fraction of current in the simultaneous presence
of TEA and melatonin, and RFTEA is the remaining fraction
of current in the presence of TEA only. The ratio of the
apparent Kd, calculated from RFmTEA, over the real Kd,
calculated from RFm (see above), is plotted as a function of
TEA concentration in Fig. 12 B. The data points are all
above the horizontal dash-dot-dot line corresponding to the
independent binding of the two compounds. This means that
melatonin and TEA do not bind independently to Kv1.3.
The data points are also far below the solid line representing
the competition between melatonin and TEA for the same
binding site. The model describing competition of melato-
nin and TEA (solid line) for the same binding site (mutually
exclusive binding) was constructed as follows.
Assuming that the occupancy of one of the four binding
sites of melatonin is sufficient to prevent TEA from binding,
the remaining fraction (RFs) of the whole-cell current in the
simultaneous presence of melatonin and TEA at concentra-
tions [m] and [TEA], respectively, is given by
RFs
1
TEA]/KdTEA 
1 m/Kdm)4
(3)
where KdTEA  11.1 mM and Kdm  8.11 mM were deter-
mined experimentally (see details of the model calculations
in the Appendix). Taking the current in the presence of TEA
alone as 100% and solving the equation for [m], the mela-
tonin concentration that reduces the current amplitude by
50% at any TEA concentration can be calculated. From this
half-blocking melatonin concentration an apparent Kd value
for the mutually exclusive binding model can be calculated,
which will be greater than the actual 8.11 mM. The ratio of
this apparent Kd value, calculated from the model, and the
real Kd value is plotted on the graph as a function of TEA
concentration. This is represented in Fig. 12 B by the solid
line.
Data points acquired in the simultaneous presence of
TEA and melatonin fall between the two lines representing
the different models described above. This means that TEA
reduces the affinity of the melatonin binding site for its
ligand in a concentration-dependent manner (p  0.02,
ANOVA). From the same set of data the effect of melatonin
on the TEA binding site was determined. Based on 1:1
stoichiometry of TEA binding to its receptor site, the Kd
value of TEA was calculated from the remaining fraction of
current in the presence of TEA only (Kd  11.1 	 0.4 mM,
n  10). Similarly, from RFTEAm  RFs/RFm, where RFs
is defined above and RFm is the remaining fraction of
current in the presence of melatonin only, the apparent Kd
value for TEA was calculated. At constant 1.5 mM mela-
tonin concentration the apparent Kd values for 5, 10, and 20
mM TEA were 18.8 	 2.9 mM (n  4), 16.5 	 1.2 mM
(n  3), and 16.6 	 0.3 mM (n  3), respectively. The
apparent Kd over real Kd ratios at different TEA concentra-
tions were constant (p  0.595, ANOVA), and the pooled
average was 1.53 	 0.09 (n  10). This means that mela-
tonin significantly reduced the affinity of the TEA binding
site for its ligand (p  0.001).
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In summary, TEA and melatonin mutually modify the
affinity of the receptor sites for their respective ligands. This
interaction is allosteric modification because melatonin and
TEA bind to different receptors: they do not compete for the
same (or overlapping) binding site.
The block of slowly inactivating mutant (H399Y)
channels by melatonin
To get a deeper insight into the modulation of inactivation
and the state dependence of melatonin block we studied the
effect of melatonin on a Kv1.3 mutant (H399Y), which
inactivates very slowly (Fig. 13 A). Position 399 corre-
sponds to T449 in Shaker channels. This position is a major
determinant of drug binding to the extracellular mouth of
Shaker potassium channels (Kavanaugh et al., 1991; Hegin-
botham and MacKinnon, 1992). Accordingly, binding af-
finity for TEA is enhanced 40-fold by the H399Y muta-
tion (Panyi and Deutsch, 1997). At the same time amino
acid side chains in this position influence dramatically the
rate of C-type inactivation (Lo´pez-Barneo et al., 1993). Fig.
13 A shows K currents recorded in CTLL-2 cells express-
ing the H399Y mutant channels. The current inactivated
much slower than the wild-type Kv1.3 current shown in Fig.
2. The decay of the current was not monoexponential as for
the wild-type current, but the 5.4-s segments of the current
traces shown in Fig. 13 A were well fitted by the sum of two
exponential terms. Fitting longer sections of the 23.6-s-long
test pulses using the sum of two terms resulted in poor fits
and large scatter in the fitted parameters (not shown). This
is most probably the consequence of a more complex inac-
tivation of this mutant requiring more than two inactivated
states for correct fits. However, the first 5.4-s segment of the
traces included much of the decay and provided reliable
fitted parameters. The fast and the slow components of the
decay had time constants of f  253.8 ms 	 17.9 ms and
s  1766.5 	 70.9 ms, respectively (n  4). The corre-
sponding (normalized) preexponential terms were 0.40 	
0.08 and 0.37 	 0.04 for the fast and the slow components,
respectively.
Melatonin also blocks H399Y channels (trace 2 in Fig. 13
A). The dose-response curve of melatonin for H399Y chan-
nels was created using the same approach as described for
Fig. 10. Peak currents were measured during test pulses to
40 mV from a holding potential of 120 mV in control
solution and at different concentrations of melatonin in the
bath. Fig. 13 B shows the remaining fraction of current at
different melatonin concentrations for cells expressing
H399Y channels along with data from Fig. 10 obtained for
Kv1.3 in peripheral blood lymphocytes. The data points and
fitted dose response curves using model IIa are practically
identical. The fitted Kd value of melatonin for the H399Y
channels is 8.4 mM, which is very close to 8.11 mM
determined for Kv1.3. This means that the dramatic slowing
FIGURE 13 Melatonin affinity is unaffected by the H399Y mutation.
(A) A CTLL-2 cell expressing Kv1.3 H399Y mutant gene displayed
whole-cell outward currents when the membrane potential was changed
from a holding potential of 120 mV to 40 mV. A 5.4-s-long segment
of 23.6-s-long depolarization is shown before (trace 1) and after the
application of 1.5 mM melatonin (trace 2). Sampling frequency was 666
Hz. (B) The unblocked fraction of the peak current (I/I0) was calculated and
plotted at different melatonin concentrations. I0 and I are the peak currents
measured in the control solution and in solutions containing different
concentrations of melatonin, respectively, at 40 mV test potential (hold-
ing potential  120 mV). Hollow circles indicate points measured on
wild-type Kv1.3 channels in human T cells, filled circles represent points
measured on H399Y mutant channels in CTLL-2 cells. Error bars indicate
SE (n 3–11). The dashed line is the binding curve fitted to the data points
measured on wild-type channels based on a 4:1 drug/channel stoichiome-
try, when one bound melatonin molecule is sufficient to block the channel.
The solid line is the curve fitted to the points measured on mutant channels
based on the same model.
1292 Varga et al.
Biophysical Journal 80(3) 1280–1297
of the inactivation gating of H399Y channels has no con-
sequence on melatonin binding.
In the presence of melatonin the inactivation rate of the
H399Y current was increased (Fig. 13 A). The characteristic
values of the decay in the presence of 1.5 mM melatonin
became f 51.6	 12.8 s and s 511	 145.7 ms (n 4).
The normalized preexponential terms became 0.52	 0.02 and
0.30	 0.12 for the fast and slow components, respectively, so
both the decreased time constants and the increased weight of
the faster component are responsible for the faster kinetics of
inactivation in the presence of melatonin.
DISCUSSION
Human peripheral blood T-lymphocytes express a variety of
ion channels (Cahalan and Lewis, 1990) among which the
most abundant types are voltage-gated (Kv1.3) and Ca2-
activated potassium channels (Matteson and Deutsch, 1984;
Cahalan et al., 1985; Grissmer et al., 1993). The relative
weight of these channels over other channel types was
increased by mitogen stimulation of T cells by PHA (Levy
and Deutsch, 1996; Grissmer et al., 1993). At the same time,
the pipette filling solution used in this study contained 140
mM KF and 11 mM EGTA providing free Ca2 concentra-
tion in the low nM range, thereby excluding the contribution
of Ca2 activated K channels to the whole-cell current
(Grissmer et al., 1993). Therefore, the contamination of
whole-cell currents by channels other than Kv1.3 was neg-
ligible. Thus, the block of Kv1.3 channels by melatonin was
studied in this paper.
We found that melatonin reduced the whole-cell K
current of PHA-activated human T cells in a dose-depen-
dent manner. The following lines of evidence support that
melatonin blocks Kv1.3 channels: 1) the effect of melatonin
is reversible (Fig. 2 A); 2) the reversal potential of the
current was not changed by melatonin; 3) the normalized
voltage-dependence of steady-state activation (Fig. 3 A) and
inactivation (Fig. 3 B) curves recorded in control solution
and in the presence of melatonin assume the same values at
holding potentials more negative than 120 mV and test
potentials more positive than 40 mV. In addition, the
midpoint of activation (V1⁄2,a) was the same in the presence
and absence of melatonin. This means that melatonin does
not reduce the current by shifting the voltage-dependence of
gating similarly to the action of HaTx on drk1 K channels
(Swartz and MacKinnon, 1997a, b). Thus, the reduction of
the conductance is the consequence of block of potassium
channels.
Melatonin block is voltage-independent
We studied the voltage dependence of block by analyzing
the instantaneous tail currents in the presence and absence
of melatonin. We showed in single-channel experiments
(Fig. 6) that melatonin block is extremely fast, therefore the
amplitude of the instantaneous tail current measured at the
beginning of the test pulse following the activating pulse is
a true measure of the number of channels not blocked by
melatonin at that particular voltage. If melatonin block were
voltage-dependent, the shape of the open channel current-
voltage function obtained in the presence of melatonin
would differ in shape from that obtained without melatonin.
In our case the current-voltage functions were linear, and
those recorded in the presence of melatonin were the scaled-
down versions of those recorded under control conditions,
meaning that the block by melatonin is voltage-independent
(Fig. 4).
However, at test potentials below 40 mV the block is
virtually voltage-dependent. We reported an increased slope
factor (sa) of the Boltzmann function fitted to the normal-
ized conductance-voltage relationship (Fig. 3 A) in the pres-
ence of melatonin. We do not understand at this moment the
nature of change in sa. If melatonin bound to the closed state
of the channel with higher affinity we would expect a shift
in V1⁄2,a without changing sa (Hille, 1992). Melatonin-in-
duced alteration of the equivalent gating charge would
change both V1⁄2,a and sa. We think, therefore, that change in
sa might reflect changes in the gating of channels that are
not blocked by melatonin. We believe that this effect of
melatonin is independent of binding to its receptor mediat-
ing channel block.
The increase in sa, however, can explain the left shift in
the voltage dependence of steady-state inactivation (h
curve). Fig. 3 A shows that the voltage dependence of
normalized steady-state activation displays lower activation
threshold and higher values below V1⁄2,a in the presence of
melatonin as compared to control. Since inactivation of
Kv1.3 is linked to the activation pathway (Marom and
Levitan, 1994; Decoursey, 1990; Panyi et al., 1995), a shift
in the h curve is expected in the presence of melatonin.
Indeed, Fig. 3 B shows that the shift in the h curve is
comparable to the shift in the activation threshold predicted
by the fit of Boltzmann distribution to the points shown in
Fig. 3 A.
Melatonin block and the gating state of Kv1.3
A key issue in the interpretation of the dose response curve
shown in Fig. 10 is that the block is state- and voltage-
independent. This was addressed in several experiments in
the paper. The voltage dependence of the block was ad-
dressed above.
Several results support that the open-to-inactivated tran-
sition is not critical for melatonin block. 1) A quantitatively
identical degree of block was achieved regardless of the
length of the depolarizing pulse (50 ms vs. 1000–2000 ms)
and the concomitant degree of inactivation at the end of the
pulse (20–25% vs. 90%). 2) During repetitive depolar-
izations with long pulses, causing high degrees of inactiva-
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tion (95%), the block of potassium current did not accu-
mulate from pulse to pulse in the continuous presence of
melatonin (Fig. 2 C). 3) As compared to the wild-type
current the inactivation of the H399Y mutant current is very
slow and multiexponential (Fig. 13 A). This dramatic dif-
ference in the inactivation behavior of the mutant channels
is not associated with any significant influence on melatonin
binding (Fig. 13 B).
Melatonin block does not accumulate in the closed state
of the channels either (Fig. 9). Application of melatonin to
the closed channels for several minutes (protocol B in Fig.
9) resulted in current block similar to the one determined
right after the start of melatonin application (protocol A in
Fig. 9).
Our single-channel results, however, do not exclude the
possibility of open state block with very high block rate.
The fact that the unitary current is reduced in the presence
of melatonin (Fig. 6) is compatible with this scenario. Our
interpretation of the reduction in the average single-channel
current amplitude is that the transition between the conduct-
ing (no melatonin bound) and the nonconducting (melatonin
bound) states is very fast, so that blocked periods are too
brief to be resolvable using our recording apparatus. In-
stead, an average of the currents from the open and blocked
periods is recorded, similarly to the block of Shaker K
channels by TEA (Spruce et al., 1987).
Results discussed above do not provide sufficient evi-
dence for preferential association of melatonin with the
closed, open, or inactivated state of Kv1.3. Regardless of
melatonin binding to either the closed or open states of the
channel, the fast rates of block and unblock indicated by
single-channel data provide instantaneous equilibration of
melatonin-bound and melatonin-free states. Thus, reduction
of the peak currents in the presence of melatonin indicates
equilibrium block of channels and therefore dose response
curves shown in Fig. 10 can be analyzed.
Modulation of inactivation
Binding of TEA to the pore of open K channels and
inactivation are mutually exclusive; TEA-blocked channels
cannot inactivate. This, in combination with the fast block-
unblock rates, results in a decrease in the rate of macro-
scopic current inactivation in the presence of TEA (Griss-
mer and Cahalan, 1989). In contrast, melatonin speeds
C-type inactivation of Kv1.3 in a concentration-dependent
fashion (Figs. 2 and 7). The values of b/c (Fig. 7) obtained
at different melatonin concentrations show significant cor-
relation (r  0.923, p  0.009) with the blocked fraction
of the current (calculated from the remaining fraction of
current shown in Fig. 10). This means that larger fractions
of melatonin-bound channels lead to faster inactivation.
Thus, our interpretation of the increased inactivation rate of
the current in the presence of melatonin is that melatonin-
bound channels inactivate faster and melatonin binding may
modulate the cooperative interaction between subunits lead-
ing to C-type inactivation (Panyi et al., 1995). We do not
currently know the relationship between the inactivation
kinetics and the number of melatonin molecules bound to
the channels. At the same time the kinetics of recovery from
inactivation was the same regardless of the presence or
absence of melatonin (Fig. 8). The simplest interpretations
compatible with our results are that melatonin does not bind
to the inactivated state of the channels or melatonin remains
bound but does not affect the kinetics of recovery from
inactivation.
Four independent melatonin binding sites
All of the results discussed above support the idea that peak
currents measured in the presence of melatonin represent
equilibrium block of Kv1.3 channels. Accordingly, the
dose-response curve constructed from peak currents mea-
sured at 0.5–10 mM extracellular melatonin was analyzed in
Fig. 10. The simplest 1:1 melatonin to channel stoichiom-
etry model gave a poor fit to the measured data, especially
at higher concentrations. Although multiple amino acid side
chains located on different subunits of a tetrameric channel
(MacKinnon, 1991) contribute to the formation of a single
binding site for ChTx (Goldstein et al., 1994) and TEA
(Heginbotham and MacKinnon, 1992), the dose response
curves are well described using 1:1 stoichiometry of binding
for these blockers. Thus, we proposed three other models
with four independent binding sites for melatonin on each
channel to account for the observed dose response curve. In
this respect the binding of melatonin to the channel is
similar to that of HaTx (Swartz and MacKinnon, 1997a, b).
However, our experiments showed that melatonin, unlike
HaTx, fully blocks the channel even if only a single mole-
cule binds to it. The binding of a second, third, or fourth
molecule has no further effect on the channel conductance.
This model (IIa) was chosen as the best based on its lowest
residual sum of squares when compared with experimental
data. The other three models investigated were clearly in-
ferior in this respect.
The validity of model IIa could be further tested by
recording the washout kinetics of the drug. If melatonin
were applied at a concentration close to saturation, when
nearly 100% of the sites are occupied, the washout kinetics
of the current would follow a sigmoidal time course (Swartz
and MacKinnon, 1997a). In practice, however, we could not
use this experiment to prove the validity of our model for
two reasons. First, due to the fast off-rate of the drug the
recovery of the current from melatonin block is much faster
than the recovery of the channels from inactivation (Levy
and Deutsch, 1996). Thus, if we tried to resolve washout
kinetics by frequent pulsing, cumulative inactivation would
develop (Marom and Levitan, 1994). Second, to saturate
95% of the binding sites melatonin should be applied at
100 times the half-blocking concentration. Due to the
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high dissociation constant this would yield an irrationally
concentrated drug solution.
Single-channel experiments also argue against stepwise
decreases in the single-channel conductance induced by
binding of individual melatonin molecules (model IIc). In
case of stepwise changes in the conductance one would
expect multiple peaks in the all-points histogram in the
presence of melatonin. If those peaks were not distinguish-
able due to the small single-channel currents and large
standard deviations one should observe an apparent increase
in the standard deviation of the Gaussian distribution fitted
to the conducting state. In contrast, the all-points histogram
in the presence of melatonin has a single peak correspond-
ing to the conducting state with reduced mean but identical
standard deviation to the control (Fig. 6).
In light of our best-fitting model to the dose response
curve (model IIa) very fast transitions between 0 or 1
melatonin-bound (blocked) states are responsible for re-
duced single-channel current in the presence of melatonin.
Using model IIa, at 5 mM melatonin concentration 50% of
the channels have 0 or 1 melatonin molecule bound and
therefore participate in such transitions.
Avdonin and Hoshi reported recently that indole, a struc-
tural analog of melatonin (indole gives the backbone of
melatonin, Fig. 1), inhibits Shaker potassium channels with
a 4:1 drug-to-channel stoichiometry, similarly to melatonin
(Avdonin and Hoshi, 2000). This strongly supports our
conclusions for the existence of four independent binding
sites.
Where is the melatonin binding site?
The following lines of evidence support that the binding site
for melatonin is located on the extracellular surface of the
channels: 1) block develops instantly after the start of mel-
atonin application to the extracellular solution. In contrast,
membrane-permeable drugs blocking potassium channels
from the intracellular side often require several minutes to
reach equilibrium block (Snyders et al., 1991; Snyders and
Chaudray, 1996; Kirsch and Drewe, 1993). The washout
kinetics for these blockers is also slow (10 min), which is
in clear contrast to our findings that relief of melatonin
block is instantaneous after switching to drug-free extracel-
lular solution. 2) The presence of melatonin in the pipette
solution (1.5 mM) did not influence the reduction of whole-
cell peak currents by extracellular application of 1.5 mM
melatonin. If melatonin were binding to the cytosolic sur-
face of the channels, then the effect of extracellular appli-
cation of melatonin would be diminished or absent in the
presence of melatonin in the pipette solution, but our results
show just the opposite.
Simultaneous application of ChTx and melatonin showed
that these two agents can bind independently to Kv1.3.
ChTx binds to the extracellular vestibule of Shaker potas-
sium channels and prevents the access of TEA, a small pore
blocker (8 Å in diameter; Kavanaugh et al., 1991) to its
binding site, i.e., their binding is mutually exclusive (Gold-
stein and Miller, 1993). Thus, the melatonin binding site
should be outside the pore, and most likely outside the
footprint of close contact residues between ChTx and the
channel vestibule, which primarily influence ChTx binding
(Goldstein et al., 1994). In addition, Fig. 5 shows that
inward and outward currents are blocked to the same extent
by melatonin. If melatonin were a pore-blocker, then inter-
action of the blocker with permeant ions would be expected
(Demo and Yellen, 1991; Hille, 1992). This was not the case
for melatonin (Fig. 5).
Allosteric interaction of melatonin and
TEA binding
We found that the simultaneous presence of melatonin and
TEA decreased the affinity of these drugs for Kv1.3. The
following lines of evidence support that this is an allosteric
modulation of separate (nonoverlapping) binding sites: 1)
the relative Kd value for melatonin in the presence of
different concentrations of TEA clearly deviates from pure
competitive binding (Fig. 12); 2) simultaneous occupancy
of ChTx and melatonin binding sites is possible (see above);
however, ChTx and TEA compete for the same or overlap-
ping binding sites.
We propose that allosteric modification of the TEA bind-
ing site by melatonin contributes to the modulation of
inactivation kinetics of Kv1.3 in the presence of melatonin.
The nature of amino acid side chains and their physical state
at the TEA binding site (position 399) dramatically influ-
ence the rate and extent of inactivation in Shaker potassium
channels and TEA affinity. Mutations at the TEA binding
site can speed up, slow down, or even disrupt C-type inac-
tivation (Lo´pez-Barneo et al., 1993). Thus, the increased
inactivation rate of Kv1.3 could be, at least partially, attrib-
uted to the effect of melatonin on critical residues deter-
mining C-type inactivation.
In conclusion, we described a unique pattern of interac-
tions of melatonin with Kv1.3 channels leading to the block
of K current. The block was state- and voltage-indepen-
dent (in a certain region of the voltage axis) and was not
compatible with either the pore occlusion mechanism or the
gating modifier mechanism described in the literature. Fur-
thermore, the best fit to the dose response curve suggested
that four independent binding sites existed for melatonin
and the occupancy of one of these sites was sufficient for
full block of the channels. These effects of melatonin were
purely pharmacological because the doses applied in this
study were several orders of magnitude higher than the peak
serum melatonin concentration in humans; however, struc-
tural analogs of melatonin with much higher affinity for
Kv1.3 might serve as templates for drug development. Sim-
ilarly, several non-peptide inhibitors of Kv1.3 were reported
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recently with potential therapeutic consequences. Further
experiments are planned to elucidate the details of the
blocking mechanism and location of the binding site of
melatonin.
APPENDIX
To determine whether melatonin and TEA compete for overlapping bind-
ing sites we had to calculate how the relative Kd value would change as a
function of TEA concentration if there were competition between them.
If the assumptions that one bound melatonin molecule prevents TEA
from binding and bound TEA prevents melatonin from binding are made,
the conducting fraction of channels can be determined. If melatonin bound
to the channel in a 1:1 manner, similarly to TEA, the respective dissocia-
tion constants would be
KdTEA
[O][TEA]
[O TEA] and Kd
m,1:1
[O][m]
[Om] .
In the equation [m] is the melatonin and [TEA] is the TEA concentration,
[O  TEA], [O  m], and [O] represent the fraction of channels blocked
by TEA, blocked by melatonin, and not blocked by either compound,
respectively. Kdm,1:1 represents the theoretical dissociation constant of mel-
atonin in a 1:1 interaction.
Since [O]  [O  TEA]  [O  m]  1, the remaining fraction (RF)
of the whole-cell current would be given by
RF
1
TEA/KdTEA [m]/Kdm,1:1 1
,
This equation does not account for the four binding sites. To replace
Kdm,1:1 by the real individual dissociation constant (Kdm) one must ask the
question: at what [m]/Kdm ratio will the 4:1 stoichiometry formula yield the
same RF as the 1:1 stoichiometry formula at [m]/Kdm,1:1 ratio in the
presence of melatonin alone? The relationship is the following:
m]
Kdm,1:1
1[m]Kdm 
4
1.
Thus, if the above substitution is made, the remaining fraction of the
whole-cell current becomes
RF
1
[TEA]/KdTEA 
1 m]/Kdm)4
,
where KdTEA  11.1 mM and Kdm  8.11 mM. Solving the equation for [m]
we get
[m]  1RF TEAKdTEA 
1/4
Kdm .
The melatonin concentration that reduces the current amplitude by 50%
(taking the current in the presence of TEA alone as 100%) at any TEA
concentration can be calculated using the formula. In this case RF will be
half of what it would be in the presence of TEA alone, thus
RF
KdTEA
2
KdTEA [TEA])
.
With this substitution the equation becomes
m 2 TEAKdTEA 
1/4
 1Kdm
From this half-blocking melatonin concentration an apparent Kd value can
be determined, which will be greater than the actual 8.11 mM. The relative
Kd value is the ratio of this apparent and real Kd values. This is plotted in
Fig. 12 as a function of TEA concentration.
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